Search research articles
Contact Us
Filters
Showing results (161-170 of 189) with videos related to
Page
of 19
Sort By:
Molecular Psychiatry
|
February 8, 2008
Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder
M J Lan, G A McLoughlin, J L Griffin, et al.
Acta Psychiatrica Scandinavica
|
February 3, 2009
Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies
M A Frye, L Yatham, T A Ketter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 18, 2004
Functional genomics and proteomics: application in neurosciences
K E Wilson, M M Ryan, J E Prime, et al.
Journal of Proteome Research
|
November 18, 2009
Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia
L Wang, H E Lockstone, P C Guest, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2007
Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland
Dimitrios Karantanis, Trond V Bogsrud, Gregory A Wiseman, et al.
American Journal of Ophthalmology
|
September 12, 2003
Optic neuropathy of Graves disease: results of transantral orbital decompression and long-term follow-up in 215 patients
Cacia V Soares-Welch, Vahab Fatourechi, George B Bartley, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 21, 2006
Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy
Marius N Stan, James A Garrity, Elizabeth A Bradley, et al.
Translational Psychiatry
|
July 15, 2015
Serum proteomic profiling of major depressive disorder
M Bot, M K Chan, R Jansen, et al.
Molecular Psychiatry
|
June 30, 2010
Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients
M Herberth, D Koethe, T M K Cheng, et al.
Developmental Biology
|
April 20, 1999
Distinct 5' SCL enhancers direct transcription to developing brain, spinal cord, and endothelium: neural expression is mediated by GATA factor binding sites
A M Sinclair, B Göttgens, L M Barton, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 189) with videos related to
Sort By:
Page
of 19
Molecular Psychiatry
|
February 8, 2008
Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder
M J Lan, G A McLoughlin, J L Griffin, et al.
Acta Psychiatrica Scandinavica
|
February 3, 2009
Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies
M A Frye, L Yatham, T A Ketter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 18, 2004
Functional genomics and proteomics: application in neurosciences
K E Wilson, M M Ryan, J E Prime, et al.
Journal of Proteome Research
|
November 18, 2009
Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia
L Wang, H E Lockstone, P C Guest, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2007
Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland
Dimitrios Karantanis, Trond V Bogsrud, Gregory A Wiseman, et al.
American Journal of Ophthalmology
|
September 12, 2003
Optic neuropathy of Graves disease: results of transantral orbital decompression and long-term follow-up in 215 patients
Cacia V Soares-Welch, Vahab Fatourechi, George B Bartley, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 21, 2006
Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy
Marius N Stan, James A Garrity, Elizabeth A Bradley, et al.
Translational Psychiatry
|
July 15, 2015
Serum proteomic profiling of major depressive disorder
M Bot, M K Chan, R Jansen, et al.
Molecular Psychiatry
|
June 30, 2010
Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients
M Herberth, D Koethe, T M K Cheng, et al.
Developmental Biology
|
April 20, 1999
Distinct 5' SCL enhancers direct transcription to developing brain, spinal cord, and endothelium: neural expression is mediated by GATA factor binding sites
A M Sinclair, B Göttgens, L M Barton, et al.
Page
of 19